Cancer incidence in kidney transplant recipients: a study protocol
<p>Abstract</p> <p>Background</p> <p>Different publications show an increased incidence of neoplasms in renal transplant patients. The objective of this study is to determine the incidence of cancer in the recipients of renal transplants performed in the A Coruña Hospit...
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2009-08-01
|
| Series: | BMC Cancer |
| Online Access: | http://www.biomedcentral.com/1471-2407/9/294 |
| _version_ | 1830440240554180608 |
|---|---|
| author | Seoane-Pillado Maria Pertega-Diaz Sonia Valdes-Cañedo Francisco Pita-Fernandez Salvador Seijo-Bestilleiro Rocio |
| author_facet | Seoane-Pillado Maria Pertega-Diaz Sonia Valdes-Cañedo Francisco Pita-Fernandez Salvador Seijo-Bestilleiro Rocio |
| author_sort | Seoane-Pillado Maria |
| collection | DOAJ |
| description | <p>Abstract</p> <p>Background</p> <p>Different publications show an increased incidence of neoplasms in renal transplant patients. The objective of this study is to determine the incidence of cancer in the recipients of renal transplants performed in the A Coruña Hospital (Spain) during the period 1981–2007.</p> <p>Methods/Design</p> <p>During the study period 1967 kidney transplants were performed, corresponding to 1710 patients. Patients with neoplasms prior to the transplant will be excluded (n = 38). A follow-up study was carried out in order to estimate cancer incidence after transplantation.</p> <p>For each patient, information included donor and recipient characteristics, patients and graft survival and cancer incidence after transplantation. Incident cancer is considered as new cases of cancer after the transplant with anatomopathological confirmation. Their location will be classified according to the ICD-9.</p> <p>The analysis will be calculated using the indirect standardisation method. Age-adjusted cancer incidence rates in the Spanish general population will be obtained from the Carlos III Health Institute, the National Epidemiology Centre of the Ministry of Science and Technology. Crude first, second and third-year post-transplantation cancer incidence rates will be calculated for male and female recipients. The number of cases of cancer at each site will be calculated from data in the clinical records. The expected number of cancers will be calculated from data supplied by the Carlos III Health Institute. For each tumour location we will estimate the standardized incidence ratios (SIRs), using sex-specific cancer incidence rates, by dividing the incidence rate for the transplant patients by the rate of the general population. The 95% confidence intervals of the SIRs and their associated p-values will be calculated by assuming that the observed cancers follow a Poisson distribution. Stratified analysis will be performed to examine the variation in the SIRs with sex and length of follow-up.</p> <p>Competing risk survival analysis methods will be applied to estimate the cumulative incidence of cancer and to identify variables associated to its occurrence.</p> <p>Discussion</p> <p>Information about cancer incidence in kidney transplant patients could be useful to adapt the guidelines on post-kidney transplant follow-up on tumour screening, and evaluate the impact of intervention measures for the prevention of cancer in these patients.</p> |
| first_indexed | 2024-12-21T04:58:19Z |
| format | Article |
| id | doaj.art-8381bfcf173a4c46b1ea03d1ac63a0e6 |
| institution | Directory Open Access Journal |
| issn | 1471-2407 |
| language | English |
| last_indexed | 2024-12-21T04:58:19Z |
| publishDate | 2009-08-01 |
| publisher | BMC |
| record_format | Article |
| series | BMC Cancer |
| spelling | doaj.art-8381bfcf173a4c46b1ea03d1ac63a0e62022-12-21T19:15:18ZengBMCBMC Cancer1471-24072009-08-019129410.1186/1471-2407-9-294Cancer incidence in kidney transplant recipients: a study protocolSeoane-Pillado MariaPertega-Diaz SoniaValdes-Cañedo FranciscoPita-Fernandez SalvadorSeijo-Bestilleiro Rocio<p>Abstract</p> <p>Background</p> <p>Different publications show an increased incidence of neoplasms in renal transplant patients. The objective of this study is to determine the incidence of cancer in the recipients of renal transplants performed in the A Coruña Hospital (Spain) during the period 1981–2007.</p> <p>Methods/Design</p> <p>During the study period 1967 kidney transplants were performed, corresponding to 1710 patients. Patients with neoplasms prior to the transplant will be excluded (n = 38). A follow-up study was carried out in order to estimate cancer incidence after transplantation.</p> <p>For each patient, information included donor and recipient characteristics, patients and graft survival and cancer incidence after transplantation. Incident cancer is considered as new cases of cancer after the transplant with anatomopathological confirmation. Their location will be classified according to the ICD-9.</p> <p>The analysis will be calculated using the indirect standardisation method. Age-adjusted cancer incidence rates in the Spanish general population will be obtained from the Carlos III Health Institute, the National Epidemiology Centre of the Ministry of Science and Technology. Crude first, second and third-year post-transplantation cancer incidence rates will be calculated for male and female recipients. The number of cases of cancer at each site will be calculated from data in the clinical records. The expected number of cancers will be calculated from data supplied by the Carlos III Health Institute. For each tumour location we will estimate the standardized incidence ratios (SIRs), using sex-specific cancer incidence rates, by dividing the incidence rate for the transplant patients by the rate of the general population. The 95% confidence intervals of the SIRs and their associated p-values will be calculated by assuming that the observed cancers follow a Poisson distribution. Stratified analysis will be performed to examine the variation in the SIRs with sex and length of follow-up.</p> <p>Competing risk survival analysis methods will be applied to estimate the cumulative incidence of cancer and to identify variables associated to its occurrence.</p> <p>Discussion</p> <p>Information about cancer incidence in kidney transplant patients could be useful to adapt the guidelines on post-kidney transplant follow-up on tumour screening, and evaluate the impact of intervention measures for the prevention of cancer in these patients.</p>http://www.biomedcentral.com/1471-2407/9/294 |
| spellingShingle | Seoane-Pillado Maria Pertega-Diaz Sonia Valdes-Cañedo Francisco Pita-Fernandez Salvador Seijo-Bestilleiro Rocio Cancer incidence in kidney transplant recipients: a study protocol BMC Cancer |
| title | Cancer incidence in kidney transplant recipients: a study protocol |
| title_full | Cancer incidence in kidney transplant recipients: a study protocol |
| title_fullStr | Cancer incidence in kidney transplant recipients: a study protocol |
| title_full_unstemmed | Cancer incidence in kidney transplant recipients: a study protocol |
| title_short | Cancer incidence in kidney transplant recipients: a study protocol |
| title_sort | cancer incidence in kidney transplant recipients a study protocol |
| url | http://www.biomedcentral.com/1471-2407/9/294 |
| work_keys_str_mv | AT seoanepilladomaria cancerincidenceinkidneytransplantrecipientsastudyprotocol AT pertegadiazsonia cancerincidenceinkidneytransplantrecipientsastudyprotocol AT valdescanedofrancisco cancerincidenceinkidneytransplantrecipientsastudyprotocol AT pitafernandezsalvador cancerincidenceinkidneytransplantrecipientsastudyprotocol AT seijobestilleirorocio cancerincidenceinkidneytransplantrecipientsastudyprotocol |